Price target upside
Larimar Therapeutics, Inc. Price Target Upside or Downside
LRMR price target upside based on the current price and analyst average.
Direct answer
Larimar Therapeutics, Inc.'s analyst target implies +238.1%.
The average target is $14.30 compared with a recorded current price of $4.23.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 10, 2026.
Get free Larimar Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.23
- Average price target
- $14.30
- High price target
- $26.00
- Low price target
- $5.00
- Target upside
- +238.1%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- August 10, 2026
- Valid through
- August 17, 2026